<?xml version="1.0" encoding="UTF-8"?>
<ref id="B72-pharmaceutics-10-00039">
 <label>72.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dalpiaz</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Contado</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Mari</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Perrone</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Pavan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Paganetto</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Hanuskov√†</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vighi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Leo</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid</article-title>
  <source>Drug Deliv.</source>
  <year>2014</year>
  <volume>21</volume>
  <fpage>221</fpage>
  <lpage>1232</lpage>
  <pub-id pub-id-type="doi">10.3109/10717544.2013.844744</pub-id>
  <?supplied-pmid 24134683?>
  <pub-id pub-id-type="pmid">24134683</pub-id>
 </element-citation>
</ref>
